P2.13-33 A Case Report of Exceptional Clinical Response to MEK Inhibition in a Patient with NRAS Mutation Positive NSCLC

Autor: Krebs, M., Graham, D., Ayub, M., Dransfield, J., Frost, H., Aruketty, S., Kilerci, B., Wallace, A., Kamboj, R., Bakhle, D., Palle, V., Sharma, S., Maharaj, N., Kumawat, R., Bhonde, M., Frese, K., Dive, C., Rothwell, D., Brady, G.
Zdroj: In Journal of Thoracic Oncology October 2018 13(10) Supplement:S811-S812
Databáze: ScienceDirect